FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Norbert Blumstein

Research Profile

Procedures

Chemicals & Drugs

Disorders

Activities & Behaviors

Image Processing, Computer-Assisted

Concepts & Ideas

Anatomy

Bone Marrow

Co-author Network

Publications

TOP 3
Bernd Neumaier; Felix Mottaghy; Andreas K Buck; Gerhard Glatting; Norbert M Blumstein; Bettina Mahren; Andreas T J Vogg; Sven N Reske
Short Communication: (18)F-immuno-PET: Determination of anti-CD66 biodistribution in a patient with high-risk leukemia.
Ludwig Rinnab; Felix Mottaghy; Joerg Simon; Bjoern G Volkmer; Robert De Petriconi; Richard E Hautmann; Markus Wittbrodt; Guenther Egghart; Peter Moeller; Norbert M Blumstein; Sven N Reske; Rainer Kuefer
[11C]Choline PET/CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer. Preliminary results of a prospective study.
Stefan Reuter; B Grüner; Andreas K Buck; Norbert M Blumstein; Peter Kern; Sven N Reske
Long-term follow-up of metabolic activity in human alveolar echinococcosis using FDG-PET.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Norbert Blumstein (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Bernd Neumaier; Felix Mottaghy; Andreas K Buck; Gerhard Glatting; Norbert M Blumstein; Bettina Mahren; Andreas T J Vogg; Sven N Reske
Short Communication: (18)F-immuno-PET: Determination of anti-CD66 biodistribution in a patient with high-risk leukemia.
Cancer biotherapy & radiopharmaceuticals 2008;23(6):819-24.
2008: Ludwig Rinnab; Felix Mottaghy; Joerg Simon; Bjoern G Volkmer; Robert De Petriconi; Richard E Hautmann; Markus Wittbrodt; Guenther Egghart; Peter Moeller; Norbert M Blumstein; Sven N Reske; Rainer Kuefer
[11C]Choline PET/CT for targeted salvage lymph node dissection in patients with biochemical recurrence after primary curative therapy for prostate cancer. Preliminary results of a prospective study.
Urologia internationalis 2008;81(2):191-7.
2008: Stefan Reuter; B Grüner; Andreas K Buck; Norbert M Blumstein; Peter Kern; Sven N Reske
Long-term follow-up of metabolic activity in human alveolar echinococcosis using FDG-PET.
Nuklearmedizin. Nuclear medicine 2008;47(4):147-52.
2008: Sven N Reske; Norbert M Blumstein; Gerhard Glatting
[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy.
European journal of nuclear medicine and molecular imaging 2008;35(1):9-17.
2007: Ludwig Rinnab; Felix Mottaghy; Norbert M Blumstein; Sven N Reske; Richard E Hautmann; Kathrin Hohl; Peter Möller; Thomas Wiegel; Rainer Kuefer; Juergen E Gschwend
Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer.
BJU international 2007;100(4):786-93.
2007: Felix Mottaghy; Cord Sunderkötter; Roland Schubert; Petra Wohlfart; Norbert M Blumstein; Bernd Neumaier; Gerhard Glatting; Cueneyt Ozdemir; Andreas K Buck; Karin Scharffetter-Kochanek; Sven N Reske
Direct comparison of [18F]FDG PET/CT with PET alone and with side-by-side PET and CT in patients with malignant melanoma.
European journal of nuclear medicine and molecular imaging 2007;34(9):1355-64.
2007: Ludwig Rinnab; Norbert M Blumstein; Felix Mottaghy; Richard E Hautmann; Rainer Küfer; Kathrin Hohl; Sven N Reske
11C-choline positron-emission tomography/computed tomography and transrectal ultrasonography for staging localized prostate cancer.
BJU international 2007;99(6):1421-6.
2007: Volker Kächele; Sandra Pauls; Felix Mottaghy; Norbert M Blumstein; Hans-Juergen Brambs; Thomas F E Barth; Andreas Hannekum; Martin Höher; Martin Jeltsch; Sven N Reske; Peter Möller; Guido Adler; Thomas Seufferlein
A 25-year-old woman with a gastric GIST and a PET-positive epicardial tumor.
Nature clinical practice. Oncology 2007;4(3):197-201.
2007: Anja Dankerl; Peter Liebisch; Gerhard Glatting; Claudia Friesen; Norbert M Blumstein; Darius Kocot; Christiane Wendl; Donald Bunjes; Sven N Reske
Multiple Myeloma: Molecular Imaging with 11C-Methionine PET/CT--Initial Experience.
Radiology 2007;242(2):498-508.
2007: Sandra Pauls; Andreas K Buck; Kathrin Hohl; Gisela Halter; Martin Hetzel; Norbert M Blumstein; Felix Mottaghy; Gerhard Glatting; S Krüger; Ludger Sunder-Plassmann; Peter Möller; Vinzenz Hombach; Hans-Juergen Brambs; Sven N Reske
Improved non-invasive T-Staging in non-small cell lung cancer by integrated 18F-FDG PET/CT.
Nuklearmedizin. Nuclear medicine 2007;46(1):9-14; quiz N1-2.
2006: S Krüger; Andreas K Buck; Norbert M Blumstein; Sandra Pauls; Hubert Schelzig; C Kropf; C Schumann; Felix Mottaghy; V Hombach; Sven N Reske
Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.
Journal of internal medicine 2006;260(6):545-50.
2006: Sven N Reske; Norbert M Blumstein; Gerhard Glatting
[PET and PET/CT in relapsing prostate carcinoma].
Der Urologe. Ausg. A 2006;45(10):1240, 1242-4, 1246-8, 1250.
2006: Gerhard Glatting; Marguerite Müller; Bernd Koop; Kathrin Hohl; Claudia Friesen; Bernd Neumaier; Eleanor Berrie; Pru Bird; Geoff Hale; Norbert M Blumstein; Herman Waldmann; Donald Bunjes; Sven N Reske
Anti-CD45 monoclonal antibody YAML568: A promising radioimmunoconjugate for targeted therapy of acute leukemia.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(8):1335-41.
2006: Sven N Reske; Norbert M Blumstein; Bernd Neumaier; Hans-Werner Gottfried; Frank Finsterbusch; Darius Kocot; Peter Möller; Gerhard Glatting; Sven Perner
Imaging prostate cancer with 11C-choline PET/CT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(8):1249-54.
2006: Sven N Reske; Norbert M Blumstein; Gerhard Glatting
[Advancement of PET and PET/CT in prostate carcinoma].
Der Urologe. Ausg. A 2006;45(6):707-10, 712-4.
2006: Thorsten Zenz; Richard F Schlenk; Gerhard Glatting; Bernd Neumaier; Norbert M Blumstein; Inga Buchmann; Stephanie von Harsdorf; Mark Ringhoffer; Markus Wiesneth; Frieder Keller; Jörg Kotzerke; Erwin M Röttinger; Stephan Stilgenbauer; Hartmut Döhner; Sven N Reske; Donald Bunjes
Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(2):278-86.
2006: Gerhard Glatting; Thomas Kull; Norbert M Blumstein; Donald Bunjes; Bernd Neumaier; Andreas K Buck; Sven N Reske
Dosimetry with (188)Re-labelled monoclonal anti-CD66 antibodies. A simplified approach based on a single measurement 3 h p.i.
Nuklearmedizin. Nuclear medicine 2006;45(3):134-8.
2005: Ludwig Rinnab; Rainer Küfer; Richard E Hautmann; Bjoern G Volkmer; Michael Straub; Norbert M Blumstein; Hans-Werner Gottfried
[Innovative concepts in early cancer detection and staging of localized prostate cancer].
Der Urologe. Ausg. A 2005;44(11):1262, 1264-6, 1268-70, 1272-5.
2005: Mark Ringhoffer; Norbert M Blumstein; Bernd Neumaier; Gerhard Glatting; Stephanie von Harsdorf; Inga Buchmann; Markus Wiesneth; Jörg Kotzerke; Thorsten Zenz; Andreas K Buck; Peter Schauwecker; Stephan Stilgenbauer; Hartmut Döhner; Sven N Reske; Donald Bunjes
188Re or 90Y-labelled anti-CD66 antibody as part of a dose-reduced conditioning regimen for patients with acute leukaemia or myelodysplastic syndrome over the age of 55: results of a phase I-II study.
British journal of haematology 2005;130(4):604-13.
2005: Malik E Juweid; Gregory A Wiseman; Julie M Vose; Justine M Ritchie; Yusuf Menda; James E Wooldridge; Felix Mottaghy; Eric M Rohren; Norbert M Blumstein; Alan H Stolpen; Brian K Link; Sven N Reske; Michael M Graham; Bruce D Cheson
Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(21):4652-61.
2005: Gerhard Glatting; Michael Landmann; Thomas Kull; Arthur P Wunderlich; Norbert M Blumstein; Andreas K Buck; Sven N Reske
Internal radionuclide therapy: the ULMDOS software for treatment planning.
Medical physics 2005;32(7):2399-405.
2004: Sven N Reske; Anja Dankerl; Gerhard Glatting; Felix Mottaghy; Norbert M Blumstein
[Significance of PET for ENT-tumors].
Laryngo- rhino- otologie 2004;83(6):391-406; quiz 407-10.